Form 4: ChromaDex Director Acquires 20,000 Stock Options
SEC Form 4 Filing
Steven D. Rubin, a director of ChromaDex Corp., acquired 20,000 stock options on June 20, 2024, exercisable for common stock.
Summary
- On June 20, 2024, Steven D. Rubin, a director of ChromaDex Corp., acquired 20,000 stock options.
- The options have an exercise price of $2.71.
- The options vest 100% on June 20, 2025, and expire on June 19, 2034.
- Following the transaction, Rubin directly owns 20,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: Director acquired 20,000 stock options. |
| 06/20/2025 | Date options vest 100%. |
| 06/19/2034 | Expiration date of the stock options. |
| 06/24/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.